Companies: 10,795·Total market cap: $144.5T

Myovant Sciences Ltd.

Myovant Sciences Ltd.

MYOVNYSEHealthcare

$26.98

$-0.01(-0.04%)

Market Cap$2.6B

P/E Ratio—

52W High$27.06

52W Low$7.67

Avg Volume1.1M

Open$26.99

Beta2.15

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Myovant Sciences Ltd.（MYOV）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · MYOV · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-1.91Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$379.1MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding93.0MShares outstanding history

Next EarningsTBAEarnings history

探索 Myovant Sciences Ltd. 数据

分析师预测$— · Buy

股息不分红

营收$231.0M+289.39%

盈利EPS $-2.22+21.55%

财务快照

FY 2022Revenue$231.0M▲ +289.39% YoY

202020212022

FY 2022Net Income-$206.0M▲ +19.27% YoY

202020212022

FY 2022EPS$-2.22▲ +21.55% YoY

202020212022

TTM:Revenue: $379.1MNet Income: -$183.8MEPS: $-1.91View income statement →

分析师评级与目标价

Buy1 位分析师

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$26.98Current

$—Avg Target

$—High

合计: 1 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Myovant Sciences Ltd.

$26.98-0.04%$2.6B #2

BELLUS Health Inc.

$14.75+0.03%$1.9B #3

Calliditas Therapeutics AB (publ)

$40.00-0.10%$1.1B #4

DICE Therapeutics, Inc.

$47.55+0.06%$2.3B #5

Fusion Pharmaceuticals Inc.

$21.55+0.14%$1.8B #6

Chinook Therapeutics, Inc.

$40.39+0.22%$2.7B

股票表现

1D+0.00%

1W+0.00%

1M-0.04%

3M+0.30%

YTD+0.19%

1Y+86.07%

5Y+27.93%

关于 Myovant Sciences Ltd.

CEODavid C. Marek

IPO DateOct 27, 2016

Employees579

CountryGB

Websitemyovant.com

Myovant Sciences Ltd. a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotrop…

Biotechnology HealthcareNYSEGB

关于股票概览与关键数据

Myovant Sciences Ltd.（MYOV）是 Biotechnology 行业的 Healthcare 类公司，于 Oct 27, 2016 在 NYSE 上市。截至最近交易日，MYOV 股价为 $26.98，市值约为 $2.6B。过去12个月累计回报 +86.07%，年初至今回报 +0.19%。

根据 1 位华尔街分析师，Myovant Sciences Ltd. 股票共识评级为Buy，12个月平均目标价为 $—。2022 财年 Myovant Sciences Ltd. 营收 $231.0M，净利润 -$206.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Myovant Sciences Ltd.（MYOV）股价为 $26.98，在 NYSE 上市，52周区间为 $7.67 – $27.06。

MYOV 最新股价MYOV quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议